Skip to content
News & Analysis

UK Stock News Page 171

AstraZeneca Has a ‘Best-in-Class Catalyst Path’
UK Stock News

AstraZeneca Has a ‘Best-in-Class Catalyst Path’

Goldman Sachs reaffirmed its Buy rating on AstraZeneca (LON: AZN) in a note this week, citing its “sector-leading catalyst path” as a key driver of long-term growth. Following…

2 years ago

ITM Power Shares Gain on Contract with FDE

ITM Power (LON: ITM) shares rose at the start of Thursday’s session after the company secured a contract to supply four NEPTUNE V green hydrogen units to La…

Entain Shares Down 34%, CEO Resigns

Entain shares (LON:ENT) saw a drop of more than 10% in trading yesterday following the unexpected resignation of CEO Gavin Isaacs. The departure comes after Isaacs spent just…

M&G Shares Are a Buy – Goldman Sachs

In a recent note to clients, analysts at Goldman Sachs reiterated its ‘Buy’ rating on M&G (LON: MNG) following the firm’s announcement of a majority stake acquisition in…

BP Shares Lead The FTSE 100 Higher

BP shares are a notable gainer on the FTSE 100 this morning, adding 6.30% as news that Elliott Investment Management, a leading activist investor, has acquired a stake…

Experian Remains a Top Long-Term Pick – JPMorgan

Experian’s (LON: EXPN) US Insurance Marketplace business continues to exceed expectations, with JPMorgan reaffirming its bullish stance on the stock in a note to clients this week. The…

Rolls-Royce: Could Tariffs Impact the Business?

Citi said in a note to clients this week that they believe potential tariffs would have a limited impact on Rolls-Royce (LON: RR.), given the company’s greater exposure…

Can GSK Shares Maintain Recent Momentum?

GSK’s shares (LON: GSK) have gained 8.96% year-to-date, after an impressive earnings report helped the stock to a 7.6% gain in yesterday’s session. However, with the share price…

Stay ahead of the markets

Sign up to our free Morning Markets email, every weekday before the open.